Dr. Brian D. Vaillant, MD

Dr. Vaillant practices at Texas Oncology PA in Kyle, Texas.

Dr. Vaillant's NPI, 1922119890, was assigned on August 31, 2006. Dr. Vaillant graduated from University of Wisconsin-Madison in 2003. Dr. Vaillant holds Texas license N1934.

Dr. Vaillant's primary practice is Texas Oncology PA, at 211 Elmhurst Dr, Kyle, TX 78640 in Hays County. The practice phone is (972) 997-8000.

Dr. Vaillant's primary practice is Texas Oncology PA in Kyle, Texas. Dr. Vaillant is also affiliated with St. David's Medical Center. The medical group on file is Seton Family of Doctors. Dmand AI also links Dr. Vaillant to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaillant practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Vaillant's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Vaillant is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Vaillant's licenses on file in 3 states: Texas, California and Washington.

Dmand AI lists cerebrovascular disease, encephalopathy, epilepsy, head injury, hereditary polyneuropathy, migraine and chronic headache, nerve damage and neuropathy among the conditions Dr. Vaillant treats.

CMS data shows 5,798 Medicare services from Dr. Vaillant across 13 procedure codes in 2024, for 280 Medicare patients. Medicare paid $138,418 for them. Every service was in an office.

CMS counts 280 Medicare patients who saw Dr. Vaillant in 2024. The largest group is 65 to 74, with 139 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaillant's median patient age at 60, with 57% women.

In 2024, Dr. Vaillant wrote 1,106 Medicare Part D claims for 137 patients. 94% of them were for generic drugs. CMS names the drug for 856 of them, across 29 drugs with 11 or more claims each, at $395,948 in total drug cost. In 2023, CMS named 771 claims across 28 drugs.

Dr. Vaillant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaillant as offering telehealth.

Dmand AI links 17 papers to Dr. Vaillant, published from 2012 to 2024. The most frequent topics are Brain Neoplasms, Glioma and Amino Acid Sequence. Dr. Vaillant's most frequent co-authors are Kenneth D. Aldape, MD, Howard Colman, MD and John F. De Groot, MD.

CMS Open Payments shows 50 general payments to Dr. Vaillant from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $283.

Dr. Vaillant graduated from University of Wisconsin-Madison in 2003.

Dr. Vaillant is in network with 22 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.